The Food and Drug Administration FDA approved Tradjenta, a new oral medication for the control of glucose levels in the blood of people that have Type 2 diabetes. Tradjenta should be stored at room temperature (not near direct light or moisture) so the bathroom is NOT a good place to store this drug.
The recommended dosing is 5 mg only once a day and most patients give this a very high rating for the ease of use. The cost is currently high, if your insurance carrier does not significantly cover the cost, ask your doctor about a discount card for the drug Tradjenta.
FDA Approved Tradjenta – Type 2 Diabetics hopeful
In the United States alone, there are more than 24 million people that have diabetes and 95% of this number has diabetes Type 2. Because of this, people with diabetes have difficultly breaking down carbohydrates due to the fact that insulin (protein needed for this function) is not working properly.
The FDA approved Tradjenta oral drug blocks DPP-4 enzymes, which releases hormones that are insulin boosting and this in turn controls the level of blood sugar in the body.
The drug companies Bristol-Myers Squibb and Merck and Company, Inc. have drugs, similar to the recently FDA approved Tradjenta, already on the market in the United States. Drugs specifically used for diabetic patients account for close to $20 billion dollar in sales.
Boehringer Ingelheim and Eli Lilly, the makers of the now FDA approved Tradjenta drug, have presented 8 clinical studies using close to four thousand human volunteers/patients.
In these studies, Tradjenta has proved consistent improvement in controlling blood sugar levels when compared to patients that were given “sugar pills” or placebos. These clinical studies have followed the strict guidelines that the FDA has put into place.
The main office of Boehringer is based in Germany and also has an office base in Danbury, Connecticut (United States). Eli Lilly and Company is home based in Indianapolis, USA.
The FDA approved Tradjenta can be used alone as a treatment for diabetes or in combination with current drugs also available such as Metformin. Many patients that have to deal with diabetes need a combination of medications to successfully control their glucose levels.
Side effects from the FDA Approved Tradjenta
Some of the minor side effects of the FDA approved Tradjenta oral drug are sore throats, headaches, clogged nasal passages, chronic cough, pain in your muscles, and respiratory infections.
Stomach pain, hives or rash, swelling of your tongue or face, labored breathing and a tight feeling in your chest, are all considered severe allergic reactions. Seek immediate medical attention if you encounter any of these reactions while taking the FDA approved Tradjenta.
Linagliptin is the generic name for this FDA approved Tradjenta, an effective pill in controlling blood sugar levels in Type 2 diabetic patients.